Table 2.
Average difference () in marker of adiposity in offspring at 3 and 18 months of age pooled, and at respective visits for 1-unit (ng/mL) increase in maternal pregnancy serum PFAA concentration.
| Compound (ng/mL) | BMI SDS | Ponderal index SDS | Waist circumference SDS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| (95% CI) | p | a | (95% CI) | p | a | (95% CI) | p | a | |
| PFHxS pooled 3 and 18 months | |||||||||
| Crudeb | 0.04 (, 0.25) | 0.68 | 0.07 (, 0.28) | 0.48 | (, 0.18) | 0.94 | |||
| Adjustedc | 0.04 (, 0.24) | 0.67 | 0.90 | 0.08 (, 0.29) | 0.43 | 0.69 | 0.01 (, 0.19) | 0.95 | 0.62 |
| Respective visits | |||||||||
| Birthd | 0.19 (, 0.43) | 0.11 | 0.24 (0.01, 0.47) | 0.05 | 0.13 (, 0.36) | 0.28 | |||
| 3 monthse | 0.05 (, 0.28) | 0.66 | 0.10 (, 0.33) | 0.42 | 0.03 (, 0.25) | 0.76 | |||
| 18 monthse | 0.04 (, 0.26) | 0.76 | 0.05 (, 0.29) | 0.67 | (, 0.20) | 0.84 | |||
| PFOS pooled 3 and 18 months | |||||||||
| Crudeb | (, 0.01) | 0.46 | (, 0.02) | 0.62 | (, 0.004) | 0.12 | |||
| Adjustedc | (, 0.01) | 0.53 | 0.84 | (, 0.02) | 0.77 | 0.85 | (, 0.01) | 0.31 | 0.18 |
| Respective visits | |||||||||
| Birthd | 0.02 (, 0.04) | 0.15 | 0.03 (0.01, 0.05) | 0.02 | 0.001 (, 0.02) | 0.95 | |||
| 3 monthse | (, 0.02) | 0.63 | (, 0.016) | 0.63 | (, 0.004) | 0.13 | |||
| 18 monthse | (, 0.02) | 0.52 | (, 0.020) | 0.78 | (, 0.02) | 0.93 | |||
| PFOA pooled 3 and 18 months | |||||||||
| Crudeb | 0.03 (, 0.08) | 0.35 | 0.05 (, 0.11) | 0.06 | (, 0.04) | 0.73 | |||
| Adjustedc | 0.04 (, 0.10) | 0.14 | 0.42 | 0.07 (0.01, 0.13) | 0.02 | 0.43 | 0.01 (, 0.07) | 0.62 | 0.06 |
| Respective visits | |||||||||
| Birthd | 0.02 (, 0.09) | 0.50 | 0.05 (, 0.12) | 0.10 | (, 0.05) | 0.59 | |||
| 3 monthse | 0.03 (, 0.10) | 0.29 | 0.06 (, 0.12) | 0.07 | (, 0.05) | 0.72 | |||
| 18 monthse | 0.06 (, 0.13) | 0.09 | 0.09 (0.02, 0.16) | 0.02 | 0.05 (, 0.12) | 0.13 | |||
| PFNA pooled 3 and 18 months | |||||||||
| Crudeb | 0.13 (, 0.30) | 0.13 | 0.20 (0.03, 0.36) | 0.02 | 0.03 (, 0.18) | 0.70 | |||
| Adjustedc | 0.18 (0.02, 0.34) | 0.03 | 0.74 | 0.24 (0.08, 0.41) | 0.82 | 0.09 (, 0.24) | 0.25 | 0.62 | |
| Respective visits | |||||||||
| Birthd | (, 0.15) | 0.65 | 0.03 (, 0.21) | 0.79 | (, 0.09) | 0.28 | |||
| 3 monthse | 0.17 (, 0.35) | 0.07 | 0.23 (0.05, 0.42) | 0.01 | 0.07 (, 0.24) | 0.45 | |||
| 18 monthse | 0.20 (0.01, 0.39) | 0.04 | 0.25 (0.06, 0.45) | 0.01 | 0.12 (, 0.30) | 0.22 | |||
| PFDA pooled 3 and 18 months | |||||||||
| Crudeb | 0.33 (, 0.76) | 0.13 | 0.53 (0.11, 0.96) | 0.02 | 0.03 (, 0.42) | 0.90 | |||
| Adjustedc | 0.42 (0.01, 0.84) | 0.05 | 0.89 | 0.60 (0.18, 1.02) | 0.92 | 0.10 (, 0.49) | 0.60 | 0.97 | |
| Respective visits | |||||||||
| Birthd | 0.08 (, 0.56) | 0.74 | 0.20 (, 0.67) | 0.41 | (, 0.41) | 0.78 | |||
| 3 monthse | 0.41 (, 0.87) | 0.08 | 0.61 (0.14, 1.07) | 0.01 | 0.10 (, 0.54) | 0.66 | |||
| 18 monthse | 0.38 (, 0.88) | 0.12 | 0.59 (0.07, 1.10) | 0.03 | 0.11 (, 0.57) | 0.65 | |||
Note: BMI, body mass index; CI, confidence interval; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexane sulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonic acid; SDS, standard deviation scores.
Interaction between the compound and visit (3 months or 18 months), tested with the likelihood-ratio test.
Mixed modeling ( for BMI SDS and ponderal index SDS, for waist circumference SDS).
Mixed modeling: Adjusted for maternal age, parity, prepregnancy BMI, prepregnancy , educational level, smoking, sex, visit, and adiposity marker at birth. ( for BMI SDS and ponderal index SDS, for waist circumference SDS).
Linear regression: Adjusted for maternal age, parity, prepregnancy BMI, prepregnancy , educational level, smoking, and sex. ( for BMI SDS and ponderal index SDS, for waist circumference SDS).
Mixed modeling: Adjusted for maternal age, parity, prepregnancy BMI, prepregnancy , educational level, smoking, sex, and adiposity marker at birth. ( for BMI SDS and ponderal index SDS; for waist circumference SDS).